Jennifer Gamlen
Family · Scottsdale, AZNPI 1942856539
Payments from drug & device makers
Across 124 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$808
- AbbVie$441
- Lilly USA, LLC$242
- Amneal Pharmaceuticals LLC$228
- Pfizer$159
- Boehringer Ingelheim$127
- plus $400 from 11 others
What the payments were for
- Food & beverage$2,403100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $808 |
| AbbVie | 26 | $441 |
| Lilly USA, LLC | 16 | $242 |
| Amneal Pharmaceuticals LLC | 13 | $228 |
| Pfizer | 9 | $159 |
| Boehringer Ingelheim | 8 | $127 |
| Exact Sciences | 3 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Amgen | 3 | $54 |
| Sanofi Pasteur Inc. | 2 | $49 |
| Novo Nordisk | 3 | $47 |
| Averitas Pharma Inc. | 1 | $31 |
| Nevro Corp. | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Qiagen, LLC | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,403 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 16 | $25,225 |
| JanuviaSitagliptin Phosphate | 11 | $9,864 |
| SynthroidLevothyroxine Sodium | 19 | $1,589 |
| Levothyroxine Sodium | 135 | $1,152 |
| Atorvastatin Calcium | 92 | $810 |
| Losartan Potassium | 76 | $668 |
| Rosuvastatin Calcium | 81 | $622 |
| Amlodipine Besylate | 60 | $577 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $539 |
| Duloxetine Hcl | 35 | $507 |
| Gabapentin | 39 | $492 |
| Trazodone Hcl | 39 | $365 |
| Lorazepam | 32 | $348 |
| Pantoprazole Sodium | 31 | $336 |
| Metformin Hcl | 25 | $328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $47 | $25,22516 claims |
| AbbVieSynthroid | $441 | $1,58919 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $228 | $1,239154 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,119 family providers in Arizona.
Other family in Scottsdale
- Kaitlyn LouchheimScottsdale$208K
- Jennifer PrinceScottsdale$76K
- Camilla BinksScottsdale$62K
- Jessica TapiaScottsdale$36K
- Dawn MougelScottsdale$34K
- Keegan RussellScottsdale$28K
- Jamie HowardScottsdale$14K
- Anna CramerScottsdale$14K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.